Abstract
972P Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in advanced hepatocellular carcinoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.annonc.2023.09.2117
Journal: Annals of Oncology | Publication Date: Oct 1, 2023 |
972P Sequential therapies after atezolizumab plus bevacizumab or lenvatinib first-line treatments in advanced hepatocellular carcinoma
Join us for a 30 min session where you can share your feedback and ask us any queries you have